GlaxoSmithKline | GSK - Market Capitalization

Stock Price
1,862.50
Daily Change
-10.00 -0.53%
Monthly
-12.27%
Yearly
33.56%
Q2 Forecast
1,829.35

GlaxoSmithKline reported GBP77.24B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 364.22B 20.46B May/2026
Alcon AG USD 24.12B 12.94B May/2026
Almirall EUR 2.51B 251.72M May/2026
Amgen USD 189.89B 13.64B Mar/2026
argenx SE USD 39.98B 4.4B May/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Bayer EUR 37.69B 1.01B May/2026
Biogen USD 26.9B 1.09B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Fresenius EUR 22.59B 5B May/2026
Fresenius Medical Care EUR 10.89B 429.56M May/2026
Genmab DKK 20.48B 1.02B Dec/2025
Gilead Sciences USD 167.39B 5.6B May/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
GRIFOLS EUR 3.69B 1.9B May/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Lakefront Biotherapeutics EUR 1.58B 147.61M May/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 52.48B 826.08M May/2026
Merck USD 297.1B 35.84B Mar/2026
Novartis USD 232.75B 75B May/2026
Novo Nordisk A/S DKK 1.45T 421.31B May/2026
Orion EUR 9.83B 890.75M Mar/2026
Pfizer USD 147.4B 6.42B May/2026
Philips EUR 21.43B 1.05B May/2026
Recordati EUR 10.41B 261.71M May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
Smith & Nephew USD 3.62B 9.7B May/2026
UCB EUR 46.41B 13.94B Dec/2025